GlassScriptPhysician profile
Matthew Parker Willis
NPI 1912027491
$497,600.81
in general payments reported to CMS, 2019-2025
14 companies · $97K in 2025
The $97K reported for 2025 was more than what 97% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113K · 2020: $59K · 2021: $20K · 2022: $69K · 2023: $76K · 2024: $64K · 2025: $97K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $215K · Travel and Lodging: $14K · Food and Beverage: $7,800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $215,018.75 |
| Travel and Lodging | $14,438.13 |
| Food and Beverage | $7,799.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $492,879.48 | 2019-2025 | Blueprint Patient Specific Instrumentation, Aequalis Perform, Tornier Perform Reversed Glenoid |
| Alpha Orthopedic Systems | $3,717.26 | 2019-2023 | |
| Catalyst Orthoscience | $278.40 | 2024 | Catalyst Csr Shoulder System, R1 Reverse Shoulder System |
| Depuy Synthes Sales INC. | $234.89 | 2022 | |
| Smith+Nephew, INC. | $159.00 | 2019 | |
| Exactech, INC. | $138.40 | 2021 | |
| Zimmer Biomet Holdings, INC. | $50.70 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $33.51 | 2025 | |
| Bioventus LLC | $26.55 | 2025 | Xcell |
| Innovation Technologies INC | $19.34 | 2025 | Irrisept |
| Sanofi-Aventis U.S. LLC | $16.69 | 2019 | |
| Music City Medical Technologies, LLC | $16.41 | 2025 | |
| Avanos Medical | $15.78 | 2019 | |
| Horizon Therapeutics Plc | $14.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Willis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.